Perspective Therapeutics (CATX)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from CATX's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Perspective Therapeutics's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $11M | $0 | $1M | — | — |
| Net income | -$7M | -$11M | -$47M | -$79M | -$103M |
| Free cash flow | -$8M | -$11M | -$38M | -$73M | -$95M |
| EPS (diluted) | -$0.50 | -$0.80 | -$1.74 | -$1.23 | -$1.40 |
| Operating margin | -59.5% | — | -2855.0% | — | — |
Superinvestors who own CATX
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $95,473 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Perspective Therapeutics's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Nov 13, 2025 | Jonathan Robert Hunt |
11,000 | $2.03 | $22,330 |
| Nov 12, 2025 | Robert F Williamson Iii |
9,498 | $2.10 | $19,946 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when CATX trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Perspective Therapeutics insiders buying the stock?
2 open-market insider purchases of CATX in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Perspective Therapeutics?
1 of the superinvestors Investingly tracks hold CATX in their latest 13F, including Cliff Asness.
Companies like Perspective Therapeutics
All Healthcare stocks · Medical Devices stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.